Cargando…
Postmarketing pharmacovigilance: Remdesivir and cardiovascular events
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010259/ https://www.ncbi.nlm.nih.gov/pubmed/35303401 http://dx.doi.org/10.1111/cts.13261 |
| _version_ | 1784687446729949184 |
|---|---|
| author | Sullivan, John T. |
| author_facet | Sullivan, John T. |
| author_sort | Sullivan, John T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9010259 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90102592022-04-18 Postmarketing pharmacovigilance: Remdesivir and cardiovascular events Sullivan, John T. Clin Transl Sci Perspectives John Wiley and Sons Inc. 2022-03-18 2022-04 /pmc/articles/PMC9010259/ /pubmed/35303401 http://dx.doi.org/10.1111/cts.13261 Text en © 2022 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Perspectives Sullivan, John T. Postmarketing pharmacovigilance: Remdesivir and cardiovascular events |
| title | Postmarketing pharmacovigilance: Remdesivir and cardiovascular events |
| title_full | Postmarketing pharmacovigilance: Remdesivir and cardiovascular events |
| title_fullStr | Postmarketing pharmacovigilance: Remdesivir and cardiovascular events |
| title_full_unstemmed | Postmarketing pharmacovigilance: Remdesivir and cardiovascular events |
| title_short | Postmarketing pharmacovigilance: Remdesivir and cardiovascular events |
| title_sort | postmarketing pharmacovigilance: remdesivir and cardiovascular events |
| topic | Perspectives |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010259/ https://www.ncbi.nlm.nih.gov/pubmed/35303401 http://dx.doi.org/10.1111/cts.13261 |
| work_keys_str_mv | AT sullivanjohnt postmarketingpharmacovigilanceremdesivirandcardiovascularevents |